Trial Profile
Pharmacokinetic interactions between telaprevir and antiretroviral drugs in HIV/HCV-coinfected patients with advanced liver fibrosis and prior HCV non-responders.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Feb 2016
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Amprenavir; Atazanavir; Darunavir; Raltegravir; Tenofovir
- Indications Hepatitis C
- Focus Pharmacokinetics
- 26 Feb 2016 New trial record